In this subgroup of pMMR CRC, the higher TGF-β levels produced by CAFs lead to the exclusion of CD4+ and CD8+ T cells from the tumor center and, therefore, to ICIs inefficacy [32]. This evidence concerns the gene TGFB1 and colorectal carcinoma.